Skip to main content
HEPA filings

Corporate insider profile

Gary S. Stetz Ii Filing Activity

Latest reported as Corporate insider of Hepion Pharmaceuticals, Inc. (HEPA).

Purchase filings
1
Reported companies
1
Net open-market value
$25,000
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Hepion Pharmaceuticals, Inc. (HEPA)Corporate insiderOpen Market Purchase500,000$0.05$25,000